Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Astellas To Set Up Branch Office In Chengdu

This article was originally published in PharmAsia News

Executive Summary

Japanese drug R&D corporation Astellas, ranked 35th on the Fortune 500 list in 2008, will establish a branch office in Chengdu to handle business in southwest and northwest China. The new office will be in charge of marketing promotion in the western region, along with bringing the world's most updated drug information, healthcare developments and market trends to hospitals and doctors. Depending on the market situation, the firm does not rule out the possibility of setting up a pharmaceutical plant or R&D center in the city. Texas Instruments is another Fortune 500 company setting up a base in Chengdu. (Click here for more - Chinese Language)

Related Content

Astellas Forecasts Earnings Decline; Says Urology Franchise Will Drive Global Growth



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts